Galapagos (GLPG)
(Delayed Data from NSDQ)
$32.56 USD
-0.32 (-0.97%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $32.56 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/23/2025
Time: AMC |
6/2025 | $-0.67 | -177.61% |
Earnings Summary
For their last quarter, Galapagos (GLPG) reported earnings of $0.39 per share, beating the Zacks Consensus Estimate of $-0.12 per share. This reflects a positive earnings surprise of 425.00%. Look out for GLPG's next earnings release on February 12, 2025.
Earnings History
Price & Consensus
Zacks News for GLPG
Biotech Stock Roundup: REGN's Drug Approval, LXRX, RYTM Stocks Gain on Update & More
GLPG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Galapagos (GLPG) Up on FDA Nod to Begin Phase I/II Lymphoma Study
GLPG FAQs
Galapagos NV (GLPG) has announced they will report their next quarter earnings on July 23, 2025. For the next earning release, we expect the company to report earnings of $-0.67 per share, reflecting a year-over-year decrease of %.
Galapagos NV has announced they will report their previous quarter earnings after the close of the market on July 23, 2025.
The Zacks Consensus Estimate for Galapagos NV (GLPG) for the quarter ending in June 2025 is $-0.67 a share. We expect Galapagos NV to miss by -177.61%.
In the earnings report for the quarter ending in March 2024, Galapagos NV (GLPG) announced earnings of $0.39 per share versus the Zacks Consensus Estimate of $-0.12 per share, representing a surprise of -425.00%.